NVO
Novo Nordisk A/S (NVO) Investor Questions
Review Novo Nordisk A/S (NVO) faq with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Company
- Novo Nordisk A/S
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Overall BTI score
- 84
- Annual revenue
- $47.03B
- Annual net income
- $15.59B
- Annual free cash flow
- $4.41B
Novo Nordisk A/S (NVO) Investor Questions research
Novo Nordisk A/S trades under the ticker NVO. The company is classified in the Healthcare sector and the Drug Manufacturers - General industry.
Investors commonly review NVO through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.